EIRGENIX INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.2 TWD | +0.37% |
|
+1.25% | -19.20% |
ETFs positioned on EirGenix Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 112 M€ | +5.51% | - | |
| 0.00% | 34 M€ | +4.26% | - |
EirGenix Inc is a Taiwan-based company primarily engaged in the development of antibody drugs and the manufacture of biopharmaceuticals. Its main businesses include the provision of Contract Development & Manufacturing Organization (CDMO) services, the construction of cell strain, the manufacture of clinical trial medicine, analytical science and protein identification, and PIC/S manufacturing plant to provide clinical trial drug production.
Sector
Pharmaceuticals
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
81.2
TWD
Average target price
132.5
TWD
Spread / Average Target
+63.18%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.20% | 771M | |
| -1.14% | 91.42B | |
| +3.16% | 41.08B | |
| -11.10% | 34.26B | |
| +53.99% | 25.27B | |
| -9.41% | 12.81B | |
| -12.25% | 11.6B | |
| -44.00% | 11.42B | |
| +5.77% | 9.16B | |
| -6.90% | 8.22B |
- Stock Market
- Equities
- 6589 Stock
- Funds and ETFs EirGenix Inc.